Form 4: Hims & Hers Chief Commercial Officer Executes Stock Option and Sells Shares
SEC Form 4 Filing
Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., exercised stock options and sold shares on November 11, 2024, according to a recent SEC filing.
Summary
- Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc., engaged in multiple transactions involving the company's Class A Common Stock on November 11, 2024.
- He exercised 7,259 stock options at a price of $6.82 per share.
- Following the exercise, he sold 7,259 shares at a price of $24.77 per share.
- Additionally, he gifted 10,000 shares to a Donor Advised Fund.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
- After these transactions, Mr. Chi directly owns 183,980 shares of Class A Common Stock and 152,439 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neither positive nor negative in itself. It reflects routine activity.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.
Comparison to Industry Standards
- The use of a Rule 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
- The vesting schedule of the stock options is typical for executive compensation packages, designed to incentivize long-term performance.
- The sale of shares after exercising options is a standard practice for executives to realize the value of their equity compensation.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are unlikely to cause significant fluctuations.
- The disclosure provides transparency to shareholders regarding executive compensation and trading activity.
Key Dates
| Date | Description |
|---|---|
| 2022-09-10 | Start date for the vesting of the stock options, with 1/48th vesting on this date. |
| 2024-03-01 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 2024-11-11 | Date of the stock option exercise, share sale, and gift transactions. |
| 2024-11-13 | Date the SEC Form 4 was signed. |
| 2032-08-10 | Expiration date of the stock options. |
Keywords
Hims & Hers, HIMS, stock options, insider trading, Rule 10b5-1, SEC Form 4, executive compensation, share sale, equity transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.